A shadow market for unlicensed slimming drugs is propelled by social media fitness personalities and vendors on communication apps, according to new investigations.
Experimental Treatment Acquiring Popularity Online
Retatrutide, which is still in clinical trials, is being promoted by online personalities for its alleged fat-burning effects. Followers are urged to message these accounts directly for supplier links, while also receiving discount codes.
Active Commerce on Messaging Platforms
Separately, a robust trade exists on Telegram, where groups with thousands of members share “before and after” images, injection guides and assertions of next-day British shipping. Vendors market the drug there before redirecting buyers to WhatsApp for purchases.
Understanding Retatrutide
Retatrutide is an experimental injectable developed by US drugmaker Eli Lilly. The treatment targets three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and pancreatic hormone. Early trials suggest it could assist patients lose up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.
Medical Experts Express Worries
However, doctors and pharmacists have cautions that the sale of what remains an unapproved medication in the UK is worrisome and could result in users injecting substances of unknown origin.
Several experts said the popularity for the experimental drug could be linked to the increasing cost of approved slimming products such as Mounjaro.
Regulatory Position and Implementation
Selling the unapproved drug on TikTok or Telegram is prohibited in the United Kingdom, as it is an unlicensed drug that must not be promoted or supplied for human use under the Human Medicines Regulations 2012.
Some content creators attempt to circumvent the regulations by calling to the substance as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted substance, but advertising and supply can still violate medicines, advertising, and consumer regulations, risking penalties, legal action or imprisonment.
Service Reaction and Material Removal
According to the social media company, the service has removed problematic content and banned related hashtags and query recommendations. The organization said it was committed to maintaining the service secure and investing in strengthening compliance measures.
Online Marketplace Activities
Research also discovered groups with up to nine thousand members marketing the experimental drug using Telegram's integrated discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of members, populated with photos of weight loss, positive testimonials and step-by-step instructions for preparing or injecting at home.
After moments of joining one group, a vendor shared contact information, where most transactions take place. The seller provided an guidebook and promised shipping within two days. When asked whether the substance was authentic, one vendor responded: “You can’t be sure.” Another provided a image of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.
Product Details and Costs
Within these groups, messages display dark colored parcels with Royal Mail labels, claiming to include fresh supplies. One message read: “It took eight of us to load them this morning.”
Buyers can select between powder vials, mixed at home with purified liquid, or pre-filled pens usually sold at £160 for 20 milligrams. When asked how long a injector should be used, sellers give conflicting responses ranging from a several days to “depends on your body”.
Platform Moderation and Safety Actions
A spokesperson for Telegram said it actively moderated dangerous material on its platform including material that promoted the “misuse of controlled medications”. The company added that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“Individuals are administering materials they can’t verify. Although the science behind this drug is sound, these digital products may not contain what they advertise,” stated Jason Murphy, the director of pharmaceutical services at a pharmacy service.
Dr Crystal Wyllie of Asda Online Doctor linked the surge in interest to current price rises for approved slimming medications such as Mounjaro. “With prices rising, patients are using online platforms. But counterfeit treatments are highly dangerous. You cannot know what’s contained or whether the conditions they were produced in was clean,” she said.
Her staff has previously seen individuals harmed by self-injection from unconfirmed sources. “We understand the frustration, but buying from Telegram or WhatsApp is taking chances with your well-being,” said the doctor. “These substances could be impure or improperly measured.”
Producer Statement
A spokesperson from Eli Lilly said retatrutide was in phase 3 research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can market [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a company investigational product not yet approved … may expose patients to possibly serious health risks”.
